Leukotriene antagonists for first-line or add-on asthma therapy – American Pharmacists Association, pharmacist.com

Leukotriene antagonists for first-line or add-on asthma therapy
American Pharmacists Association, pharmacist.com
Key point: In patients with asthma, leukotriene-receptor antagonists (LTRAs) managed the disease just as successfully as inhaled glucocorticoid for first-line therapy or long-acting beta-2 agonist as add-on therapy. Finer points: Two parallel,

View full post on asthma – Google News

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.